Navigation Links
Antipsychotic Drug Linked to Pulmonary Embolism

A case study published in the British Medical Journal suggests a common antipsychotic drug might have caused a pulmonary embolism in an otherwise healthy young man.//

A pulmonary embolism results when a blood clot that developed elsewhere in the body travels to the lung. The result can be deadly. Antipsychotic drugs have been linked to an increased risk of blood clots in the past. Specifically, studies have shown an association between blood clots and the drug clozapine.

Investigators from Norway outline the experiences of a 28-year-old man who was admitted to the hospital with a psychotic disorder. Doctors began treatment with the antipsychotic drug olanzapine at 10 milligrams per day, gradually upping the dose to 30 milligrams per day. The man also received various other medications.

After 10 weeks of treatment, the man began to complain of respiratory pain. A clinical examination showed no shortness of breath, fever, or other factors normally associated with respiratory disease. A lung scan, however, found a pulmonary embolism in the man’s left lower lobe. He was put on standard anticoagulation treatment and he recovered. Olanzapine was discontinued and the man began receiving another drug instead.

Though olanzapine is associated with weight gain, and its sedating effects might lead to inactivity -- thus predisposing someone to develop blood clots -- researchers say the man in this study did not gain additional weight after receiving olanzapine. His activity level also remained normal. Tests for blood clotting disorders also turned up negative. They say that leaves olanzapine as the primary suspect in the development of the man’s pulmonary embolism.


'"/>




Page: 1

Related medicine news :

1. New Antipsychotic Medications have Little Advantage Over Older Drugs
2. Antipsychotics – not effective in treating Alzheimer
3. No Evidence to Support Many Off-label Uses of Atypical Antipsychotics
4. Antipsychotic Drug Controls Some Symptoms in Autism Disorder
5. Scientists Uncover Cause of Antipsychotic Drug Weight Gain
6. Study Sheds Light on Value of Newer Antipsychotic Drugs for Schizophrenia
7. Low Cholesterol Linked to Severe Depression and Violent Behavior in Men
8. Cough Syrup Ingredient Linked to Stroke
9. Irregular Periods Linked to Diabetes
10. Hormones Linked To Migraines
11. Triglycerides Linked To Stroke Risk
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2017)... ... April 28, 2017 , ... ... pilot study of ActiGraph’s CentrePoint Data Hub in a sample of ... of clinical-grade wearable activity and sleep monitoring solutions for the global scientific community. ...
(Date:4/28/2017)... ... ... NuevaCare, a leading home care agency based in San Mateo, California, but ... to announce information upgrades to its blog in the form of WordPress tags. The ... as home care (generally) as well as senior care and home care agency issues. ...
(Date:4/27/2017)... ... April 27, 2017 , ... ... respiratory hospital, based in Denver, Colorado, announced an agreement to create the Jane ... continuing support of the Jane and Leonard Korman Family Foundation. The collaboration leverages ...
(Date:4/27/2017)... ... April 27, 2017 , ... The American Brain Foundation last ... in Neurology Award (PLINA). The couple joins a prestigious list of past PLINA ... Mondale, actor Michael J. Fox and former U.S. Attorney General Janet Reno. , ...
(Date:4/27/2017)... ... April 27, 2017 , ... Offering the purest product of its ... times purer and more potent than the market has seen before. Swissx uses proprietary ... well as a patented chromatography process for extraction, to produce its CBD oil--maximizing its ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), ... address significant unmet medical needs, today announced that ... consumer product development program, based on its proprietary ... Investigative Dermatology (SID) 76 th Annual Meeting.  ... the sciences relevant to skin health and disease ...
(Date:4/20/2017)... April 20, 2017   ZappRx, Inc ., a digital ... prescribing process, today announced it closed $25 million in Series ... capital firm based in Seattle that ... Partners . The Series B round included participation from ... 2014, and GV (formerly Google Ventures). As part ...
(Date:4/20/2017)... 2017 Eyevensys, a private biotechnology ... gene expression technology that enables the safe, local, sustained ... a wide range of ophthalmic diseases, announces it has ... Regulatory Agency (MHRA) to advance its technology into clinical ... The ...
Breaking Medicine Technology: